JP2025503969A5 - - Google Patents
Info
- Publication number
- JP2025503969A5 JP2025503969A5 JP2024544444A JP2024544444A JP2025503969A5 JP 2025503969 A5 JP2025503969 A5 JP 2025503969A5 JP 2024544444 A JP2024544444 A JP 2024544444A JP 2024544444 A JP2024544444 A JP 2024544444A JP 2025503969 A5 JP2025503969 A5 JP 2025503969A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- group
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303409P | 2022-01-26 | 2022-01-26 | |
| US63/303,409 | 2022-01-26 | ||
| US202263435210P | 2022-12-23 | 2022-12-23 | |
| US63/435,210 | 2022-12-23 | ||
| PCT/US2023/011654 WO2023146987A1 (en) | 2022-01-26 | 2023-01-26 | Compounds and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503969A JP2025503969A (ja) | 2025-02-06 |
| JP2025503969A5 true JP2025503969A5 (https=) | 2026-02-04 |
Family
ID=85328599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544444A Pending JP2025503969A (ja) | 2022-01-26 | 2023-01-26 | 化合物及び使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250136594A1 (https=) |
| EP (1) | EP4469438A1 (https=) |
| JP (1) | JP2025503969A (https=) |
| KR (1) | KR20240153335A (https=) |
| AU (1) | AU2023213736A1 (https=) |
| CA (1) | CA3243127A1 (https=) |
| IL (1) | IL314320A (https=) |
| MX (1) | MX2024009177A (https=) |
| TW (1) | TW202339736A (https=) |
| WO (1) | WO2023146987A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024022433A1 (zh) * | 2022-07-28 | 2024-02-01 | 北京望实智慧科技有限公司 | Prmt5抑制剂 |
| WO2024104244A1 (zh) * | 2022-11-15 | 2024-05-23 | 四川科伦博泰生物医药股份有限公司 | 草酸酰胺化合物、包含其的药物组合物及其制备方法和用途 |
| WO2024131918A1 (zh) * | 2022-12-22 | 2024-06-27 | 成都苑东生物制药股份有限公司 | 一种取代草酰胺类衍生物、其制备方法及用途 |
| CN120476118A (zh) * | 2023-01-17 | 2025-08-12 | 苏州浦合医药科技有限公司 | Prmt5-mta抑制剂 |
| CR20250446A (es) | 2023-04-21 | 2025-12-02 | Gilead Sciences Inc | Inhibidores de prmt5 y usos de los mismos |
| CN118290386B (zh) * | 2024-04-02 | 2025-06-20 | 国科大杭州高等研究院 | 7-羟基黄酮类化合物及其制备方法和应用 |
| WO2025217297A1 (en) | 2024-04-09 | 2025-10-16 | Tango Therapeutics, Inc. | Prmt5 inhibitors for use in methods of treating mta-accumulating cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US11077101B1 (en) * | 2018-07-18 | 2021-08-03 | Tango Therapeutics, Inc. | Compounds and methods of use |
| WO2021004547A1 (en) * | 2019-07-11 | 2021-01-14 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Heterocyclic compounds as inhibitors of hpk1 |
| WO2022026892A1 (en) * | 2020-07-31 | 2022-02-03 | Tango Therapeutics, Inc. | Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-deficient and/or mt a-accumulating cancers |
-
2023
- 2023-01-26 EP EP23706923.2A patent/EP4469438A1/en active Pending
- 2023-01-26 US US18/833,315 patent/US20250136594A1/en active Pending
- 2023-01-26 AU AU2023213736A patent/AU2023213736A1/en active Pending
- 2023-01-26 IL IL314320A patent/IL314320A/en unknown
- 2023-01-26 JP JP2024544444A patent/JP2025503969A/ja active Pending
- 2023-01-26 CA CA3243127A patent/CA3243127A1/en active Pending
- 2023-01-26 KR KR1020247028555A patent/KR20240153335A/ko active Pending
- 2023-01-26 WO PCT/US2023/011654 patent/WO2023146987A1/en not_active Ceased
- 2023-01-30 TW TW112103169A patent/TW202339736A/zh unknown
-
2024
- 2024-07-24 MX MX2024009177A patent/MX2024009177A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025503969A5 (https=) | ||
| JP7542538B2 (ja) | Ｓｒｃホモロジー－２ホスファターゼ阻害剤としての縮合三環式環誘導体 | |
| US10301278B2 (en) | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 | |
| US10774065B2 (en) | 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 | |
| CN101678014B (zh) | 杂环激酶调节剂 | |
| KR101960129B1 (ko) | 피롤로벤조디아제핀 | |
| JP6326057B2 (ja) | 置換ピリミジニルおよびピリジニル−ピロロピリジノン、これらの調製のための方法、およびキナーゼ阻害剤としてのこれらの使用 | |
| KR100774855B1 (ko) | 축합 헤테로아릴 유도체 | |
| JP2020189868A (ja) | Ｓｈｐ２阻害剤として有用な新規複素環式誘導体 | |
| US7232825B2 (en) | Phenylaminopyrimidine derivatives and methods of use | |
| ES2651765T3 (es) | Imidazopiridazinas sustituidas | |
| JP7328323B2 (ja) | ＳＭＡＲＣＡ２／ＢＲＭ ＡＴＰａｓｅ阻害剤としての尿素化合物及び組成物 | |
| CN102753547A (zh) | 三唑并吡啶衍生物 | |
| US20190016703A1 (en) | Bifunctional compounds for her3 degradation and methods of use | |
| JP2011510995A5 (https=) | ||
| JP2025514386A (ja) | 特定の化学物質、組成物、および方法 | |
| JP2025503970A5 (https=) | ||
| ES3041067T3 (en) | 4-(2-((2-chloroquinolin-4-yl)amino)ethyl)benzenesulfonamide derivatives as stat3 inhibitors for the treatment of cancer | |
| JP6913955B2 (ja) | ＰＩ３Ｋ／ｍＴＯＲ阻害剤としての溶融キノリン化合物 | |
| JP7168245B2 (ja) | 三環式化合物 | |
| TW202333667A (zh) | 嘧啶或吡啶類衍生物及其醫藥用途 | |
| CN113747894A (zh) | 成纤维细胞生长因子受体2(fgfr2)的降解剂 | |
| JP2019502680A (ja) | Ｃｘｃｒ４受容体アンタゴニスト | |
| KR101777475B1 (ko) | 신규한 디히드로피라노피리미디논 유도체 및 이들의 용도 | |
| US8916572B2 (en) | Bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinase |